Concepedia

Chenlu Wei

CW

Statistics

Publications

4

Citations

115

H-Index

4

Active since

2019

Affiliations

BeiGene (China)(Current)

Fudan University

Zhongshan Hospital

Sun Yat-sen University

The First Affiliated Hospital, Sun Yat-sen University

Chenlu Wei is an author at BeiGene (China) specializing in phagocytosis resistance, immunotherapy, and cancer immunology.

Publications per year

2019–2025

4

Publications

4

RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma

Rong Yu, Wenqing Wang, Tao Li et al. · Future Oncology · 2021 · 69 citations · Full text

Life Sciences, Immunology, Oncology +17

Self‐Cascade of ROS/Glucose‐Scavenging Immunomodulatory Hydrogels for Programmed Therapeutics of Infected Diabetic Ulcers via Nrf2/NF‐κB Pathway

Wei Meng, Xiaotong Chen, Yanyan Chen et al. · Small · 2025 · 25 citations · Full text

Natural Sciences, Bioengineering, Biomedical Engineering +17

Preliminary results with tislelizumab, an investigational anti-PD-1 antibody, in Chinese patients with nasopharyngeal cancer (NPC).

Siyang Wang, Xiaoming Huang, Yuxian Bai et al. · Journal of Clinical Oncology · 2019 · 11 citations

Medicine, Oncology, Pharmacology +17

TCTN1 Induces Fatty Acid Oxidation to Promote Melanoma Metastasis

Yinlam Li, Ren Ming, Tianyi Zhang et al. · Cancer Research · 2024 · 10 citations

Medicine, Cancer Biology, Oncology +17

1–4 of 4